PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-1.78%
Negative net income growth while MRVL stands at 163.75%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
3.61%
Some D&A expansion while MRVL is negative at -4.39%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
117.39%
Some yoy growth while MRVL is negative at -95.16%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
45.24%
SBC growth well above MRVL's 11.58%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-174.23%
Both reduce yoy usage, with MRVL at -398.19%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-161.64%
Both yoy AR lines negative, with MRVL at -155.29%. Martin Whitman would suspect an overall sector lean approach or softer demand.
185.15%
Some inventory rise while MRVL is negative at -30.89%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-415.38%
Negative yoy AP while MRVL is 140.17%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-169.12%
Negative yoy usage while MRVL is 57.98%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
19.05%
Lower 'other non-cash' growth vs. MRVL's 122.03%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-48.39%
Negative yoy CFO while MRVL is 7.54%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
22.29%
CapEx growth well above MRVL's 5.28%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-100.00%
Both yoy lines negative, with MRVL at -126.22%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
55.26%
Purchases well above MRVL's 83.81%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-26.77%
We reduce yoy sales while MRVL is 25.55%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
96.62%
We have some outflow growth while MRVL is negative at -150.22%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-22.06%
We reduce yoy invests while MRVL stands at 1024.01%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-48.60%
We cut debt repayment yoy while MRVL is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
297.37%
Issuance growth of 297.37% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
42.66%
We have some buyback growth while MRVL is negative at -2537.20%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.